FI2916856T4 - Bremelanotidin käyttöjä naisen seksuaalisen toimintahäiriön hoidossa - Google Patents

Bremelanotidin käyttöjä naisen seksuaalisen toimintahäiriön hoidossa Download PDF

Info

Publication number
FI2916856T4
FI2916856T4 FIEP13851014.4T FI13851014T FI2916856T4 FI 2916856 T4 FI2916856 T4 FI 2916856T4 FI 13851014 T FI13851014 T FI 13851014T FI 2916856 T4 FI2916856 T4 FI 2916856T4
Authority
FI
Finland
Prior art keywords
composition
bremelanotide
use according
plasma concentration
peak plasma
Prior art date
Application number
FIEP13851014.4T
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Carl Spana
Robert Jordan
Jeffrey Edelson
Original Assignee
Palatin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50628268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI2916856(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Palatin Technologies Inc filed Critical Palatin Technologies Inc
Application granted granted Critical
Publication of FI2916856T4 publication Critical patent/FI2916856T4/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
FIEP13851014.4T 2012-11-05 2013-11-05 Bremelanotidin käyttöjä naisen seksuaalisen toimintahäiriön hoidossa FI2916856T4 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722511P 2012-11-05 2012-11-05
US201361770535P 2013-02-28 2013-02-28
PCT/US2013/068386 WO2014071339A2 (en) 2012-11-05 2013-11-05 Uses of bremelanotide in therapy for female sexual dysfunction

Publications (1)

Publication Number Publication Date
FI2916856T4 true FI2916856T4 (fi) 2024-01-15

Family

ID=50628268

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP13851014.4T FI2916856T4 (fi) 2012-11-05 2013-11-05 Bremelanotidin käyttöjä naisen seksuaalisen toimintahäiriön hoidossa

Country Status (23)

Country Link
US (7) US9352013B2 (enExample)
EP (1) EP2916856B2 (enExample)
JP (1) JP6567971B2 (enExample)
KR (1) KR102253526B1 (enExample)
CN (2) CN117860866A (enExample)
AU (1) AU2013337341B2 (enExample)
BR (1) BR112015009936A8 (enExample)
DK (1) DK2916856T4 (enExample)
EA (1) EA032959B9 (enExample)
ES (1) ES2701444T5 (enExample)
FI (1) FI2916856T4 (enExample)
GE (2) GEP20196947B (enExample)
HK (1) HK1211227A1 (enExample)
IL (1) IL238276B (enExample)
MX (1) MX362610B (enExample)
MY (1) MY179755A (enExample)
NZ (1) NZ707246A (enExample)
PH (1) PH12015500915B1 (enExample)
PL (1) PL2916856T5 (enExample)
SG (1) SG11201502949QA (enExample)
UA (1) UA118656C2 (enExample)
WO (1) WO2014071339A2 (enExample)
ZA (1) ZA201503128B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension
CN119074641A (zh) * 2024-09-02 2024-12-06 万邦德制药集团有限公司 一种含布雷默浪丹药物组合物、制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235625B2 (en) * 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US7022674B2 (en) 1999-12-16 2006-04-04 Eli Lilly And Company Polypeptide compositions with improved stability
EP1289587B1 (en) * 2000-05-31 2005-08-03 Novo Nordisk A/S A disposable double pointed injection needle
CA2453515A1 (en) 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
MX2007006973A (es) * 2004-12-09 2007-08-15 West Pharm Serv Inc Acoplamiento para un dispositivo de auto-inyeccion.
WO2009120656A1 (en) * 2008-03-24 2009-10-01 Palatin Technologies, Inc. Pharmaceutical for ocular indications
WO2009152079A1 (en) * 2008-06-09 2009-12-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US9314509B2 (en) * 2009-11-16 2016-04-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
KR101850687B1 (ko) * 2010-04-21 2018-04-20 애브비 바이오테크놀로지 리미티드 치료제의 제어된 전달을 위한 착용형 자동 주사 디바이스

Also Published As

Publication number Publication date
US10286034B2 (en) 2019-05-14
JP2016503406A (ja) 2016-02-04
US20140378392A1 (en) 2014-12-25
DK2916856T3 (en) 2019-01-14
SG11201502949QA (en) 2015-06-29
US20190216888A1 (en) 2019-07-18
GEAP201813826A (en) 2018-10-25
PL2916856T5 (pl) 2024-01-29
EP2916856A2 (en) 2015-09-16
MX2015005486A (es) 2015-11-13
CA2890081A1 (en) 2014-05-08
MX362610B (es) 2019-01-28
DK2916856T4 (da) 2024-01-22
JP6567971B2 (ja) 2019-08-28
BR112015009936A8 (pt) 2019-09-17
US20220362328A1 (en) 2022-11-17
EA032959B1 (ru) 2019-08-30
MY179755A (en) 2020-11-12
CN117860866A (zh) 2024-04-12
EA201590760A1 (ru) 2015-10-30
BR112015009936A2 (pt) 2017-07-11
US9700592B2 (en) 2017-07-11
US20150231196A1 (en) 2015-08-20
AU2013337341A1 (en) 2015-05-07
PH12015500915A1 (en) 2015-06-29
US20180085425A1 (en) 2018-03-29
IL238276A0 (en) 2015-06-30
US9352013B2 (en) 2016-05-31
GEP20196947B (en) 2019-02-11
ZA201503128B (en) 2016-11-30
ES2701444T5 (es) 2024-05-21
NZ707246A (en) 2019-03-29
EP2916856B2 (en) 2023-10-18
US20210060120A1 (en) 2021-03-04
KR20150081345A (ko) 2015-07-13
ES2701444T3 (es) 2019-02-22
WO2014071339A2 (en) 2014-05-08
IL238276B (en) 2020-04-30
US20240335502A1 (en) 2024-10-10
EA032959B9 (ru) 2019-11-27
HK1211227A1 (en) 2016-05-20
CN104755094A (zh) 2015-07-01
PH12015500915B1 (en) 2015-06-29
AU2013337341B2 (en) 2018-02-22
EP2916856A4 (en) 2016-06-22
UA118656C2 (uk) 2019-02-25
PL2916856T3 (pl) 2019-02-28
EP2916856B1 (en) 2018-09-19
KR102253526B1 (ko) 2021-05-18
WO2014071339A3 (en) 2014-06-12

Similar Documents

Publication Publication Date Title
KR101882400B1 (ko) 셀룰라이트 개선성분 및 항산화 유효성분, 부종감소 및 통증완화 성분을 함유한 다이어트 주사용 조성물
MY201603A (en) Combination of dextromethorphan and bupropion for treating depression
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
UA105644C2 (uk) Способи лікування легеневих порушень складами ліпосомального амікацину
WO2014075084A3 (en) Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid
WO2007110871A3 (en) Methods and composition for treating sore throat
CN101631550A (zh) 带状疱疹后神经痛治疗用片剂以及带状疱疹后神经痛的治疗方法
PL1732551T3 (pl) Perheksylina do leczenia przewlekłej niewydolności serca
EA032959B9 (ru) Применение бремеланотида в терапии женской сексуальной дисфункции
Matsuyama et al. Etiology and management of venous pain during intravenous administration of oxaliplatin
WO2008088987B1 (en) Treatment of pain with naloxone
JP2016503406A5 (enExample)
NZ708511A (en) Methods for controlling blood pressure and reducing dyspnea in heart failure
MX2026000090A (es) Lemborexant para el tratamiento de problemas del sueño
MX2018013477A (es) Acidos carboxilicos para tratar/prevenir una enfermedad de la piel.
US20150246017A1 (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
US20160128978A1 (en) Pharmaceutical for improving dysphagia
WO2008091408A3 (en) Circulating renalase and methods of increasing same
RU2012114097A (ru) Терапевтический агент против хронической боли
MX2018013474A (es) Acidos carboxilicos para aplicacion en la primera infancia.
CN102000241A (zh) 一种用于治疗阳痿早泄的中药
CN110585188A (zh) 脂类及脂类化合物用作药物治疗疼痛及其应用方法
RU99118938A (ru) Способ лечения обострения хронического панкреатита
CN109364111A (zh) 一种药物配方方法
Fraser et al. DRAMATIC ENHANCEMENT OF ANTIMUSCARINIC RESISTANT, HIGH AMPLITUDE NONVOIDING CONTRACTIONS BY INHIBITION OF THE SYMPATHETIC NERVOUS SYSTEM: 270